Меню
Набор скоро начнётся NCT07328438

Diagnosis Disclosure Support for Caregivers of Children With Autism

Без фазы С лечением Autism Spectrum Disorder

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: SHARE : Supporting Honest Autism Recognition and Education, One-session seminar.
Кому может быть актуально
Состояния в реестре: Autism Spectrum Disorder. Базовые параметры: 7 лет — 12 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Список центров уточняется — проверьте первичный протокол.
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Diagnosis Disclosure Support Intervention Program for Caregivers of Children With ASD

Обзор

The purpose of this randomized controlled pilot study is to develop and evaluate an online diagnosis disclosure support intervention for caregivers of 7- to 12-year-old children with autism spectrum disorder (ASD) in South Korea. This intervention is designed to support caregivers who are contemplating, preparing for, or carrying out disclosure of their child's ASD diagnosis to the child. This study has three primary aims: (1) to evaluate the acceptability and feasibility of the intervention; (2) to examine clinically meaningful effects of the intervention on caregivers' psychological well-being and psychosocial adjustment (e.g., emotion regulation, loneliness/social isolation, and adaptation to life transitions), parenting competence and attitudes (e.g., parenting self-efficacy, parenting role satisfaction, and parenting stress), and autism-related knowledge and social perceptions (e.g., autism knowledge and perceived autism-related stigma); and (3) to assess whether the effects of the intervention are maintained one month after program completion.

Подробное описание

As school-aged children with autism spectrum disorder begin to recognize differences between themselves and their neurotypical peers, they develop questions regarding their identity and belonging. During this critical developmental period, receiving a clear and supportive explanation of their diagnosis can promote self-understanding, encourage self-advocacy, and enhance psychosocial adjustment. However, caregivers often face significant barriers to disclosing the diagnosis, stemming from fear of stigma, uncertainty about appropriate timing and language, and concerns about causing emotional distress. As a result, caregivers may delay or avoid disclosure, despite potential benefits for the child. Therefore, developing evidence-based interventions to support caregivers in diagnosis disclosure is significant, yet few studies offer guidance for caregivers, leaving disclosure decisions and processes largely to individual families.

The purpose of this randomized controlled pilot study is to develop and evaluate an online diagnosis disclosure support intervention for caregivers of 7- to 12-year-old children with ASD in South Korea, a developmental period when children go through increasing cognitive, social, and identity-related challenges. This study pursues three objectives: (1) to evaluate the acceptability and feasibility of the diagnosis disclosure support intervention; (2) to examine clinically meaningful effects on caregiver's outcomes across domains such as psychological well-being and psychosocial adjustment, parenting competence and attitudes, and autism-related knowledge and social perceptions; and (3) to assess the sustainability of these effects through a one-month follow-up after program completion.

40 caregivers of children with ASD enrolled in mainstream schools (grades 2-6) in South Korea will be recruited and randomly assigned to either an intervention group (n=20) or a waitlist control group (n=20). The intervention group will participate in a five-week, online group-based diagnosis disclosure support program consisting of weekly 60-minute sessions, which will be recorded for fidelity monitoring. The waitlist control group will receive an abbreviated one-session online seminar and program materials upon completion of the final follow-up assessment. Both groups will complete online self-report measures at three timepoints: baseline (T1), immediately following the intervention group's program completion (T2), and at a one-month follow-up (T3). This study holds the potential to improve caregivers' well-being and support healthy family communication by providing evidence-based guidance to facilitate developmentally appropriate disclosure for children with ASD in South Korea.

Вмешательства

  • Поведенческое SHARE : Supporting Honest Autism Recognition and Education
    Our intervention will consist of a five-week, telehealth-based group intervention (60 minutes per week) to support caregivers of children with ASD (7- to 12-year-olds) regarding diagnosis disclosure. This program provides guidance on the rationale for disclosure, strategies for initiating conversations, and the understanding that disclosure is a gradual, lifelong journey. In addition, the program helps caregivers customize disclosure based on their child's development and emotional readiness. Th
  • Поведенческое One-session seminar
    The control group will receive a 60-minute telehealth seminar providing a condensed overview of the SHARE program and the complete set of SHARE program materials.

Первичные конечные точки

  • Parental Autism Disclosure Scale (PADS) [Срок оценки: baseline, immediately after the intervention, 1-month follow-up]
  • Decisional Conflict Scale (DCS) [Срок оценки: baseline, immediately after the intervention, 1-month follow-up]
  • Diagnosis Disclosure Support Intervention Program Acceptability Survey [Срок оценки: immediately after the intervention]
  • Diagnosis Disclosure Support Intervention Program Feasibility Survey [Срок оценки: immediately after the intervention]
  • Participation Survey [Срок оценки: during each of the five sessions (weeks 1 to 5) in intervention program]
  • Intervention Fidelity Checklist [Срок оценки: every 3 months from the start of the intervention for each therapist]
Вторичные конечные точки (9)
  • Korean Version of Internalized Stigma of Mental Illness Scale (K-ISMI) [Срок оценки: baseline, immediately after the intervention, 1-month follow-up]
  • Life Transition Scale for Parents of Children with Autism (LTS) [Срок оценки: baseline, immediately after the intervention, 1-month follow-up]
  • Emotion Regulation Questionnaire (ERQ) [Срок оценки: baseline, immediately after the intervention, 1-month follow-up]
  • Autism Stigma and Knowledge Questionnaire (ASK-Q-2) [Срок оценки: baseline, immediately after the intervention, 1-month follow-up]
  • Parenting Sense of Competence (PSOC) [Срок оценки: baseline, immediately after the intervention, 1-month follow-up]
  • Parent Satisfaction Scale (PSS) [Срок оценки: baseline, immediately after the intervention, 1-month follow-up]
  • Korean Parenting Stress Index Fourth Edition Short Form (K-PSI-4-SF) [Срок оценки: baseline, immediately after the intervention, 1-month follow-up]
  • UCLA Loneliness Scale-8 (ULS-8) [Срок оценки: baseline, immediately after the intervention, 1-month follow-up]
  • Loneliness and Social Isolation Scale (LSIS) [Срок оценки: baseline, immediately after the intervention, 1-month follow-up]

Критерии участия

Критерии включения

  • Caregivers of children aged 7-12 (Grades 2-6) attending mainstream schools in South Korea
  • Caregivers of children with previous medical diagnosis of ASD
  • Caregivers with no prior experience of participation in diagnosis disclosure support programs
  • Caregivers in agreement with the need for a ASD diagnosis disclosure support intervention program, with commitment to continuous and sincere participation

Критерии исключения

  • Caregivers of children with significant intellectual disability
  • Caregivers of children with significant language delay

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Простое слепое
Основная цель
Лечение

Центры проведения

Список центров уточняется — проверьте первичный протокол.

Идентификаторы

NCT: NCT07328438 · IRB-2025-0578-01 · 00209635

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗